In trouble, don’t apply for openings in 2024 - Recensione dipendente - Dipendente anonimo presso Bayer

2,0
27 mar 2024
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

-Great people (some teams) -Excellent science -Good benefits -Industry leader products (Crop -Science)

Svantaggi

-Upper management lacks diversity beyond the token female HR leader -New CEOs is poor communicator and makes it all up as he goes -DSO roll-out is horrible and damaging to the company -EU-centric focus ignores where most of the sales occur (strategic leaders disconnected)

Esplora altre recensioni su Bayer

5,0
21 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good team , good cafeteria

Svantaggi

Bad office , bad weather

4,0
1 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Excellent compensation packages with good 401k match, health benefits, bonus percentage and vacation. Excellent colleagues and talented teams.

Svantaggi

Acquisition of Monsanto and its legal battles have hurt the company finances and sunk the stock value significantly. Due to struggling cash flows, they have been laying off talented & senior employees every year and the teams are losing talent and experienced leadership.

Vedi recensioni per: Utile|Valutazione|Data|Tutto